Anbiping Investors

Anbiping is a medical technology company that specializes in the research and development, production, and service of pathological diagnostic products. Their main focus is on tumor screening and correct diagnosis, with pathology being the main application department. They have developed a range of products and equipment for tumor screening and diagnosis, including liquid-based cytology, polymerase chain reaction, immunohistochemistry, and fluorescence in situ hybridization. These products cover different levels of clinical needs, from cell morphology to protein expression and gene testing. Anbiping is known for having one of the most extensive technical platforms and product varieties in the domestic tumor screening and diagnosis industry.

Industry: Other
Headquarters: Guangzhou, Guangdong, China
Founded Date: 2005
Investor Type: Healthcare Company
Employee Number: 251-500